Latest news
Is PepGen (NASDAQ:PEPG) In A Good Position To Invest In Growth? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 14:13:10 GMTPepGen - Cash of $117.20 Mln as of June 30, 2 - MoomooMoomoo · Fri, 07 Aug 2026 11:40:30 GMTDSMB approves dose escalation in PepGen’s FREEDOM2-DM1 study - YahooYahoo · Fri, 07 Aug 2026 10:38:11 GMTPepgen Inc. (PGN) 2026 Q2 10-Q Report: Financials, Risks, and Forward-Looking Statements Overview - MinichartMinichart · Thu, 06 Aug 2026 23:51:00 GMTPepGen advances PGN-EDODM1 into 12.5 mg/kg cohort in Phase 2 FREEDOM2-DM1 trial - BitgetBitget · Thu, 06 Aug 2026 12:22:19 GMTPepGen Q2 2026 earnings: Lower R&D spending narrows the net loss - TradingKeyTradingKey · Thu, 06 Aug 2026 12:12:51 GMTPepGen Inc. 1H 2026: Net loss $(35.6M), EPS $(0.51) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:41:01 GMTPepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - Business WireBusiness Wire · Thu, 06 Aug 2026 11:32:00 GMT